These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34911174)

  • 21. Reduction of visceral fat correlates with the decrease in the number of obesity-related cardiovascular risk factors in Japanese with Abdominal Obesity (VACATION-J Study).
    Hiuge-Shimizu A; Kishida K; Funahashi T; Ishizaka Y; Oka R; Okada M; Suzuki S; Takaya N; Nakagawa T; Fukui T; Fukuda H; Watanabe N; Yoshizumi T; Ohira T; Nakamura T; Matsuzawa Y; Yamakado M; Shimomura I
    J Atheroscler Thromb; 2012; 19(11):1006-18. PubMed ID: 22785136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of visceral fat area in patients with chronic kidney disease.
    Manabe S; Kataoka H; Mochizuki T; Iwadoh K; Ushio Y; Kawachi K; Watanabe K; Watanabe S; Akihisa T; Makabe S; Sato M; Iwasa N; Yoshida R; Sawara Y; Hanafusa N; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2021 Jun; 25(6):608-620. PubMed ID: 33595731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between visceral fat and osteoporotic vertebral compression refractures.
    Zhang P; Lin C; Chen M; He Y; Yan X; Lai J; Fan S; Li S; Teng H
    Nutrition; 2022; 103-104():111808. PubMed ID: 36063722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fat accumulation and obesity-related cardiovascular risk factors in middle-aged Japanese men and women.
    Ryo M; Funahashi T; Nakamura T; Kihara S; Kotani K; Tokunaga K; Matsuzawa Y; Shimomura I
    Intern Med; 2014; 53(4):299-305. PubMed ID: 24531085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research.
    Doyle SL; Bennett AM; Donohoe CL; Mongan AM; Howard JM; Lithander FE; Pidgeon GP; Reynolds JV; Lysaght J
    Nutr Res; 2013 Mar; 33(3):171-9. PubMed ID: 23507222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cut-Off Values for Visceral Fat Area Identifying Korean Adults at Risk for Metabolic Syndrome.
    Lee A; Kim YJ; Oh SW; Lee CM; Choi HC; Joh HK; Oh B; Hwang SS; Kim SJ; Kwon OD
    Korean J Fam Med; 2018 Jul; 39(4):239-246. PubMed ID: 29972898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects.
    Yokokawa H; Fukuda H; Saita M; Goto K; Kaku T; Miyagami T; Takahashi Y; Hamada C; Hisaoka T; Naito T
    Diabetol Metab Syndr; 2021 Apr; 13(1):44. PubMed ID: 33853648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes.
    Fukuda T; Bouchi R; Takeuchi T; Nakano Y; Murakami M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    J Diabetes Investig; 2018 Mar; 9(2):396-402. PubMed ID: 28686352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring visceral fat, subcutaneous fat and skeletal muscle area changes by computed tomography in acute pancreatitis: a retrospective, single-centre study.
    Brewster DJ; Strauss BJ; Crozier TM
    Crit Care Resusc; 2014 Mar; 16(1):42-7. PubMed ID: 24588435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese visceral adiposity index: A reliable indicator of visceral fat function associated with risk of type 2 diabetes.
    Han M; Qin P; Li Q; Qie R; Liu L; Zhao Y; Liu D; Zhang D; Guo C; Zhou Q; Tian G; Huang S; Wu X; Li Y; Yang X; Zhao Y; Feng Y; Liu Y; Li H; Sun X; Chen Q; Wang T; Chen X; Hu D; Zhang M
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3370. PubMed ID: 32562335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.
    Kim JM; Chung E; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
    Clin Nutr; 2021 Nov; 40(11):5631-5638. PubMed ID: 34662848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M
    Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral fat area and body fat percentage measured by bioelectrical impedance analysis correlate with glycometabolism.
    Li S; Li S; Ding J; Zhou W
    BMC Endocr Disord; 2022 Sep; 22(1):231. PubMed ID: 36109703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Visceral-To-Subcutaneous Fat Ratio Is Associated with an Increased Risk of Gastroesophageal Reflux Disease in Nonobese Adults.
    Koo JE; Chang HS; Park HW; Park S; Bae I; Lee JY; Choe J
    Dig Dis; 2023; 41(4):666-676. PubMed ID: 36843033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery.
    Ding Z; Wu XR; Remer EM; Lian L; Stocchi L; Li Y; McCullough A; Remzi FH; Shen B
    Colorectal Dis; 2016 Feb; 18(2):163-72. PubMed ID: 26391914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse relationship between serum Metrnl levels and visceral fat obesity (VFO) in patients with type 2 diabetes.
    Du Y; Ye X; Lu A; Zhao D; Liu J; Cheng J; Yang T
    Diabetes Res Clin Pract; 2020 Mar; 161():108068. PubMed ID: 32044349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China.
    Zheng J; Hu Y; Xu H; Lei Y; Zhang J; Zheng Q; Li L; Tu W; Chen R; Guo Q; Zang X; You Q; Xu Z; Zhou Q; Wu X
    Cardiovasc Diabetol; 2023 Jun; 22(1):137. PubMed ID: 37308932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
    Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease.
    Kataoka H; Mochizuki T; Iwadoh K; Ushio Y; Kawachi K; Watanabe S; Watanabe K; Akihisa T; Makabe S; Manabe S; Sato M; Iwasa N; Yoshida R; Sawara Y; Hanafusa N; Tsuchiya K; Nitta K
    PLoS One; 2020; 15(11):e0241626. PubMed ID: 33196670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.